Close

Let's talk.

Your Full Service Premier CDMO

Efficient CHO Stable Cell Line Development Process with High Productivity and Assured Monoclonality

Efficient CHO Stable Cell Line Development Process with High Productivity and Assured Monoclonality

Cell Line Development and Engineering Conference | June 2019

In recent years biologic drugs account for a large percentage of the growth in the
pharmaceutical industry and are continuously in high demand. Obtaining a highly
productive, single cell derived stable cell line is essential for manufacturing the
biological drug product. JOINN Biologics’ highly efficient cell line development process
can meet such growing needs and an accelerated timeline. Using a combination of
high through-put imaging, screening, single cell printing technologies and early
product analysis, we are able to evaluate every step in the CHO cell line development
process. Our optimized workflow demonstrated successful selection of clonal cell lines
with high productivity, high quality and monoclonality.

Cell Line Development Poster